189 related articles for article (PubMed ID: 12629594)
1. Radiocontrast-induced nephropathy.
Asif A; Preston RA; Roth D
Am J Ther; 2003; 10(2):137-47. PubMed ID: 12629594
[TBL] [Abstract][Full Text] [Related]
2. Prevention of radiocontrast-induced nephropathy.
Asif A; Epstein M
Am J Kidney Dis; 2004 Jul; 44(1):12-24. PubMed ID: 15211433
[TBL] [Abstract][Full Text] [Related]
3. Current trials of interventions to prevent radiocontrast-induced nephropathy.
Asif A; Garces G; Preston RA; Roth D
Am J Ther; 2005; 12(2):127-32. PubMed ID: 15767830
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience with the use of fenoldopam for prevention of radiocontrast nephropathy in high-risk patients.
Madyoon H
Rev Cardiovasc Med; 2001; 2 Suppl 1():S26-30. PubMed ID: 12439365
[TBL] [Abstract][Full Text] [Related]
5. Prophylaxis of iodinated contrast media-induced nephropathy: a pharmacological point of view.
Idé JM; Lancelot E; Pines E; Corot C
Invest Radiol; 2004 Mar; 39(3):155-70. PubMed ID: 15076008
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiology of radiocontrast nephropathy and use of fenoldopam for its prevention.
Mathur VS
Rev Cardiovasc Med; 2001; 2 Suppl 1():S4-8. PubMed ID: 12439361
[TBL] [Abstract][Full Text] [Related]
7. Design and rationale of CONTRAST--a prospective, randomized, placebo-controlled trial of fenoldopam mesylate for the prevention of radiocontrast nephropathy.
Stone GW; Tumlin JA; Madyoon H; Lepor NE; McCullough PA; Mathur VS; Murray PT; O'Neill WW
Rev Cardiovasc Med; 2001; 2 Suppl 1():S31-6. PubMed ID: 12439366
[TBL] [Abstract][Full Text] [Related]
8. Managing the high-risk patient: experience with fenoldopam, a selective dopamine receptor agonist, in prevention of radiocontrast nephropathy during percutaneous coronary intervention.
Kini AA; Sharma SK
Rev Cardiovasc Med; 2001; 2 Suppl 1():S19-25. PubMed ID: 12439364
[TBL] [Abstract][Full Text] [Related]
9. Dopamine-1 receptor agonist: renal effects and its potential role in the management of radiocontrast-induced nephropathy.
Asif A; Epstein DL; Epstein M
J Clin Pharmacol; 2004 Dec; 44(12):1342-51. PubMed ID: 15545304
[TBL] [Abstract][Full Text] [Related]
10. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy.
Kurnik BR; Allgren RL; Genter FC; Solomon RJ; Bates ER; Weisberg LS
Am J Kidney Dis; 1998 Apr; 31(4):674-80. PubMed ID: 9531185
[TBL] [Abstract][Full Text] [Related]
11. Contrast-associated nephropathy.
Soma VR; Cavusoglu E; Vidhun R; Frishman WH; Sharma SK
Heart Dis; 2002; 4(6):372-9. PubMed ID: 12441014
[TBL] [Abstract][Full Text] [Related]
12. Radiocontrast-induced acute renal failure: allocations and outcomes.
Mehran R; Ashby DT
Rev Cardiovasc Med; 2001; 2 Suppl 1():S9-13. PubMed ID: 12439362
[TBL] [Abstract][Full Text] [Related]
13. Past and present attempts to prevent radiocontrast nephropathy.
Bailey SR
Rev Cardiovasc Med; 2001; 2 Suppl 1():S14-8. PubMed ID: 12439363
[TBL] [Abstract][Full Text] [Related]
14. Clinical and experimental evidence for prevention of acute renal failure induced by radiographic contrast media.
Itoh Y; Yano T; Sendo T; Oishi R
J Pharmacol Sci; 2005 Apr; 97(4):473-88. PubMed ID: 15821342
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful.
Vogt B; Ferrari P; Schönholzer C; Marti HP; Mohaupt M; Wiederkehr M; Cereghetti C; Serra A; Huynh-Do U; Uehlinger D; Frey FJ
Am J Med; 2001 Dec; 111(9):692-8. PubMed ID: 11747848
[TBL] [Abstract][Full Text] [Related]
16. Contrast nephropathy : an evidence-based approach to prevention.
Kandzari DE; Rebeiz AG; Wang A; Sketch MH
Am J Cardiovasc Drugs; 2003; 3(6):395-405. PubMed ID: 14728060
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the prevention of radiocontrast-induced nephropathy.
Marenzi G; Bartorelli AL
Curr Opin Crit Care; 2004 Dec; 10(6):505-9. PubMed ID: 15616393
[TBL] [Abstract][Full Text] [Related]
18. Dopamine and renal blood flow in radiocontrast-induced nephropathy in humans.
Weisberg LS; Kurnik PB; Kurnik BR
Ren Fail; 1993; 15(1):61-8. PubMed ID: 8441838
[TBL] [Abstract][Full Text] [Related]
19. Role of N-acetylcysteine in the prevention of radiocontrast-induced nephropathy.
Brophy DF
Ann Pharmacother; 2002 Sep; 36(9):1466-70. PubMed ID: 12196069
[TBL] [Abstract][Full Text] [Related]
20. Radiocontrast-induced nephropathy and percutaneous coronary intervention: a review of preventive measures.
Mintz EP; Gruberg L
Expert Opin Pharmacother; 2003 May; 4(5):639-52. PubMed ID: 12739990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]